Compare UNCY & SRBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UNCY | SRBK |
|---|---|---|
| Founded | 2016 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 150.1M | 149.8M |
| IPO Year | 2021 | 2023 |
| Metric | UNCY | SRBK |
|---|---|---|
| Price | $5.29 | $19.43 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $25.67 | N/A |
| AVG Volume (30 Days) | ★ 700.4K | 20.1K |
| Earning Date | 05-13-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 1.04% |
| EPS Growth | N/A | ★ 138.36 |
| EPS | N/A | ★ 0.31 |
| Revenue | ★ $675,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $582.86 | N/A |
| P/E Ratio | ★ N/A | $62.90 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $3.72 | $14.34 |
| 52 Week High | $8.74 | $20.95 |
| Indicator | UNCY | SRBK |
|---|---|---|
| Relative Strength Index (RSI) | 48.13 | 45.72 |
| Support Level | $5.28 | $18.71 |
| Resistance Level | $5.86 | $19.61 |
| Average True Range (ATR) | 0.25 | 0.48 |
| MACD | 0.04 | -0.10 |
| Stochastic Oscillator | 46.29 | 22.04 |
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.